rs370285346
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM5PP3_Moderate
The NM_000256.3(MYBPC3):c.1445C>T(p.Ala482Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,612,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A482G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.1445C>T | p.Ala482Val | missense_variant | Exon 16 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.1445C>T | p.Ala482Val | missense_variant | Exon 15 of 34 | 5 | ENSP00000382193.2 | |||
MYBPC3 | ENST00000544791.1 | n.1445C>T | non_coding_transcript_exon_variant | Exon 16 of 27 | 5 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152110Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 246762Hom.: 0 AF XY: 0.0000374 AC XY: 5AN XY: 133832
GnomAD4 exome AF: 0.0000370 AC: 54AN: 1459970Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 26AN XY: 726100
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152110Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74294
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy Uncertain:2
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 164117). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy and/or dilated cardiomyopathy (PMID: 25351510; Invitae). This variant is present in population databases (rs370285346, gnomAD 0.02%). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 482 of the MYBPC3 protein (p.Ala482Val). -
This missense variant replaces alanine with valine at codon 482 of the MYBPC3 protein. Computational prediction suggests that this variant may have a deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with hypertrophic cardiomyopathy (PMID: 25351510, 29875424). This variant has been identified in 10/278138 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
The Ala482Val variant in MYBPC3 has not been previously reported in individuals with cardiomyopathy, but has been identified in 1/8366 European American chromos omes and 2/4082 African American chromosomes by the NHLBI Exome Sequencing Proje ct (http://evs.gs.washington.edu/EVS/). Computational prediction tools and conse rvation analysis suggest that this variant may impact the protein, though this i nformation is not predictive enough to determine pathogenicity. In summary, the clinical significance of the Ala482Val variant is uncertain. -
Left ventricular noncompaction 10 Uncertain:1
- -
Cardiomyopathy Uncertain:1
This missense variant replaces alanine with valine at codon 482 of the MYBPC3 protein. Computational prediction suggests that this variant may have a deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with hypertrophic cardiomyopathy (PMID: 25351510, 29875424). This variant has been identified in 10/278138 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Has been reported in individuals with HCM (PMID: 25351510, 29875424, 36788754); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29875424, 25351510, 36788754) -
Hypertrophic cardiomyopathy 4 Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.A482V variant (also known as c.1445C>T), located in coding exon 16 of the MYBPC3 gene, results from a C to T substitution at nucleotide position 1445. The alanine at codon 482 is replaced by valine, an amino acid with similar properties. This alteration has been reported in hypertrophic cardiomyopathy (HCM) cohorts; however, clinical details were limited (Lopes LR et al. Heart, 2015 Feb;101:294-301; Mazzarotto F et al. Genet Med, 2019 02;21:284-292). This variant has been reported in the Jackson Heart Study cohort; however, clinical details were limited (Bick AG et al. Am J Hum Genet, 2012 Sep;91:513-9). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at